TransDigm Group (NYSE:TDG – Get Free Report) is set to announce its earnings results before the market opens on Tuesday, May 7th. Analysts expect the company to announce earnings of $6.80 per share for the quarter. TransDigm Group has set its FY24 guidance at $29.97-$31.72 EPS and its FY 2024 guidance at 29.970-31.730 EPS.Investors that are interested in registering for the company’s conference call can do so using this link.
TransDigm Group (NYSE:TDG – Get Free Report) last issued its earnings results on Thursday, February 8th. The aerospace company reported $7.16 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $6.41 by $0.75. The company had revenue of $1.79 billion during the quarter, compared to analyst estimates of $1.68 billion. TransDigm Group had a negative return on equity of 59.61% and a net margin of 20.80%. The firm’s quarterly revenue was up 28.1% on a year-over-year basis. During the same quarter last year, the business posted $4.15 EPS. On average, analysts expect TransDigm Group to post $29 EPS for the current fiscal year and $35 EPS for the next fiscal year.
TransDigm Group Trading Down 0.5 %
Shares of TDG stock traded down $6.73 during mid-day trading on Tuesday, reaching $1,251.99. The stock had a trading volume of 95,980 shares, compared to its average volume of 204,735. TransDigm Group has a 1-year low of $750.86 and a 1-year high of $1,269.51. The firm has a market cap of $69.62 billion, a price-to-earnings ratio of 53.36, a PEG ratio of 2.56 and a beta of 1.42. The business’s fifty day moving average is $1,205.25 and its 200-day moving average is $1,065.56.
Wall Street Analyst Weigh In
View Our Latest Stock Report on TransDigm Group
Insider Activity at TransDigm Group
In other TransDigm Group news, Director W Nicholas Howley sold 2,391 shares of the stock in a transaction on Friday, February 16th. The shares were sold at an average price of $1,160.55, for a total transaction of $2,774,875.05. Following the transaction, the director now directly owns 21,549 shares of the company’s stock, valued at $25,008,691.95. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. In related news, Director W Nicholas Howley sold 2,391 shares of the company’s stock in a transaction dated Friday, February 16th. The shares were sold at an average price of $1,160.55, for a total transaction of $2,774,875.05. Following the completion of the transaction, the director now owns 21,549 shares in the company, valued at approximately $25,008,691.95. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, COO Joel Reiss sold 3,000 shares of TransDigm Group stock in a transaction dated Monday, April 15th. The stock was sold at an average price of $1,233.10, for a total value of $3,699,300.00. Following the completion of the sale, the chief operating officer now owns 3,600 shares in the company, valued at $4,439,160. The disclosure for this sale can be found here. In the last quarter, insiders have sold 59,087 shares of company stock valued at $69,840,358. 4.96% of the stock is owned by company insiders.
TransDigm Group Company Profile
TransDigm Group Incorporated designs, produces, and supplies aircraft components in the United States and internationally. The Power & Control segment offers mechanical/electro-mechanical actuators and controls, ignition systems and engine technology, specialized pumps and valves, power conditioning devices, specialized AC/DC electric motors and generators, batteries and chargers, databus and power controls, sensor products, switches and relay panels, hoists, winches and lifting devices, and cargo loading and handling systems.
Read More
- Five stocks we like better than TransDigm Group
- Industrial Products Stocks Investing
- NXP Semiconductors Will Set a New High Soon: $300 in Sight
- Golden Cross Stocks: Pattern, Examples and Charts
- Hilton Demonstrates Asset Light is Right for Investors
- How to Invest in the Best Canadian StocksĀ
- Boston Scientific Bucks the Medtech Slow Down and Raises Outlook
Receive News & Ratings for TransDigm Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for TransDigm Group and related companies with MarketBeat.com's FREE daily email newsletter.